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Abstract
We investigated the cross-sectional and longitudinal associations between hemoglobin concentration and hypertension in a Korean
population.
Between 2006 and 2013, we examined 4899 participants with mean age of 56.6 years (range 35–88 years) from a rural
community. We excluded 298 participants with a history of myocardial infarction or stroke and 264 participants with very low
hemoglobin levels (men: <13.3g/dL; women: <11.6g/dL). Finally, we performed a cross-sectional analysis on 1629 men and 2708
women. Longitudinal associations were evaluated in 654 men and 1099 women, after excluding 2584 people with hypertension at
baseline and those who did not participate in follow-up examinations. Hypertension was deﬁned as systolic blood pressure≥140mm
Hg, diastolic blood pressure ≥90mm Hg, or use of antihypertensive treatment.
The mean hemoglobin level was signiﬁcantly higher in people with hypertension than in those without hypertension (P=0.002 for
men, P=0.006 for women). On cross-sectional analysis, the odds ratio (95% conﬁdence interval) for hypertension per 1 standard
deviation increase in hemoglobin concentration (1.2g/dL) was 1.11 (1.05–1.18) before adjustment and 1.20 (1.09–1.32) after
adjusting for age, sex, body mass index, kidney markers, lifestyle factors, and comorbidities. On longitudinal analysis, the relative risk
(95% conﬁdence interval) for incident hypertension per 1 standard deviation increase in hemoglobin concentration was 1.09
(0.96–1.23) before adjustment and 0.91 (0.78–1.08) after adjusting for age, sex, body mass index, lifestyle factors, baseline blood
pressure, baseline comorbidities, and baseline kidney markers.
This study suggests that hemoglobin per se does not cause hypertension development.
Abbreviation: BMI = body mass index, BUN = blood urea nitrogen, CVD = cardiovascular disease, DBP = diastolic blood
pressure, KoGES = Korean Genome and Epidemiology Study, OR = odds ratio, RRs = relative risks, SBP = systolic blood pressure,
SD = standard deviation.
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The World Health Organization has reported that an estimated
17.5 million people died from cardiovascular disease (CVD) in
2012, representing 31% of all global deaths. Worldwide,
approximately 54% of stroke cases and 47% of ischemic heart
disease cases were attributable to high blood pressure.[1]
Therefore, maintaining blood pressure values at an appropriate
level and lowering risk factors to the minimal level is the key to
preventing CVD.
Recent studies have indicated that increasing levels of
hemoglobin are associated with high blood pressure and
hypertension.[2–6] However, a Chinese study recently suggested
that increasing hematocrit was not associated with prehyperten-
sion in individuals older than 60 years.[7] According to several
previous studies, high hemoglobin can cause vasoconstriction
and then elevate the blood pressure.[8,9] However, other studies
reported that blood pressure is not correlated with blood
viscosity in healthy individuals.[10–12]
Thus, we aimed to determine whether high hemoglobin per se
can cause the development of hypertension in healthy individuals.
Accordingly, we investigated both cross-sectional and longitu-
dinal associations between hemoglobin and hypertension among
community-dwelling Koreans.
Kim et al. Medicine (2016) 95:41 Medicine2. Methods
2.1. Study population
Between 2006 and 2011, we enrolled 4899 people aged 35 to 88
years and living on Kangwha Island, South Korea, in the Korean
Genome and Epidemiology Study (KoGES) and the Ischemic
Heart Disease Clinical Research Center Study. After baseline
health examinations, cohort members were invited to undergo
follow-up health examinations every 3 to 5 years. The total
follow-up period ranged from 1 to 7 years (mean 4.4 years).
A cross-sectional analysis was performed for 4337 people after
excluding those with a history of myocardial infarction (n=125)
or cerebrovascular accident (n=173), and also those with very
low hemoglobin concentrations (n=264, <13.3g/dL for men
and <11.6g/dL for women).
A longitudinal analysis was performed for 1753 people, after
additionally excluding 1096 people who did not participate in
follow-up examinations and 1488 participants who had
hypertension at baseline. All participants signed written informed
consent forms, and the study protocol was approved by the
Institutional Review Board of Severance Hospital at Yonsei
University College of Medicine.2.2. Measurements
All participants were interviewed individually using a standard-
ized questionnaire to obtain information about sociodemo-
graphic characteristics, health behaviors, and chronic diseases.
Trained interviewers conducted face-to-face interviews according
to a predeﬁned protocol, and double-checked whether responses
were appropriate.
Alcohol intake was categorized as current drinking and former/
nondrinking. Participants were asked whether they had ever
consumed alcoholic beverages in their lifetime. If they regularly
consumed at least 1 drink of any alcoholic beverage per month,
they were categorized as current alcohol drinkers. If participants
had stopped drinking or had never consumed alcohol, they were
classiﬁed as former/nondrinkers.[13] Current smokers were
deﬁned as those who had smoked more than 100 cigarettes in
their lifetime and were presently smoking. Current smokers
smoked an average of 15.7 cigarettes per day (19.8 for men, 12.2
for women). Former smokers were those who had smoked more
than 100 cigarettes in their lifetime, yet had not smoked recently,
and never smokers were deﬁned as those who had smoked fewer
than 100 cigarettes. Smoking status was assessed using a self-
reported questionnaire and was categorized as former/nonsmok-
ing and current cigarette smoking. Regular physical activity was
stratiﬁed into 2 groups based on the frequency of leisure-time
physical activity.
Standing height was measured to the nearest 0.1cm with an
extensometer (DS-102, JENIX, Korea), and body weight was
measured to the nearest 0.1kg with a digital scale (DB-150, CAS,
Korea). Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters. Resting
systolic blood pressure (SBP) and diastolic blood pressure (DBP)
were measured at least twice using an automatic oscilloscopic
sphygmomanometer (Carescape Dinamap V100, GE Health-
care). If the ﬁrst and second measurements differed by ≥10mm
Hg for SBP or DBP, then additional measurements were
performed, and the average of the last 2 measurements was
used for the current analysis. Hypertension was deﬁned as
elevated blood pressure (SBP ≥140mm Hg or DBP ≥90mm Hg)
or use of antihypertensive medication.2Blood samples were collected from the antecubital veins of the
participants, after at least 8hours of fasting. Collected blood
samples were analyzed at a central research laboratory to obtain
measurements of complete blood counts, total cholesterol,
triglycerides, fasting glucose, blood urea nitrogen (BUN), and
creatinine. Hemoglobin concentrations were measured by the
impedance method using an automatic analyzer (ADVIA 120,
Bayer Corp). Diabetes mellitus was deﬁned as elevated fasting
blood glucose (≥126mg/dL), elevated HbA1c (≥6.5%), or
treatment for diabetes. Hypercholesterolemia was deﬁned as
elevated total cholesterol (≥230mg/dL), elevated triglycerides
(≥200mg/dL), or use of lipid-lowering medication.2.3. Statistical analysis
Baseline characteristics were described for a total of 4337
participants according to sex using Student t test and the chi-
square test. Student t test, the chi-square test, and the Wilcoxon
test were used to assess statistical differences in baseline
characteristics, including hemoglobin, in relation to the preva-
lence of hypertension. Trend tests were used to determine
statistical differences in blood pressure and each covariate at
follow-up according to quartiles of baseline hemoglobin
concentration. We divided baseline hemoglobin concentrations
into 4 groups, using each quartile level for both men and women.
For the total population, we applied sex-speciﬁc quartiles. A
logistic regression analysis was conducted to assess odds ratios
(ORs) for cross-sectional associations between hemoglobin
concentrations and hypertension. A generalized linear model
was used to estimate relative risk (RR) for incident hypertension
according to baseline hemoglobin concentration. For these
analyses, we used 3 models: model 1 was an unadjusted model;
model 2 was adjusted for age, sex, BMI, and study year (only for
the cross-sectional analysis); and model 3 was additionally
adjusted for menopausal status, alcohol intake, smoking status,
regular physical activity, baseline BUN, serum creatinine,
diabetes, hypercholesterolemia, and baseline SBP (only for the
longitudinal analysis). We also performed Cox proportional
hazard regression as a sensitivity analysis of generalized linear
model. Smoking status was not included in the analysis of women
due to the very low smoking rate (2.2%). To obtain additional
insights into the linearity of the association between hemoglobin
concentration and hypertension, a penalized cubic regression
spline was used.[14] All statistical analyses were performed using
SAS software, version 9.4.0 (SAS Inc., Cary, NC) and R package,
version 3.0.3. All analyses were 2-sided, and P values less than
0.05 were regarded as statistically signiﬁcant.
3. Results
3.1. Characteristics of the study population
Baselinecharacteristics are shownseparately formenandwomen in
Table 1. Male participants were older and exhibited higher
hemoglobin, SBP,DBP, fastingglucose,BUN, serumcreatinine, and
triglyceride levels than female participants, yet had lower BMI and
total cholesterol levels. Cigarette smoking, alcohol drinking, and
regular physical activityweremore frequent inmen than inwomen.
3.2. Cross-sectional association between hemoglobin and
hypertension
Men with hypertension were older and presented with higher
BMI, fasting glucose, serum creatinine, and triglyceride levels,
Table 1
Baseline characteristics of the study participants by sex.
Variables (n=4337) Men (n=1629) Women (n=2708) P
Age, y 57.1±8.9 56.3±8.9 0.006
Body mass index, kg/m2 24.4±2.8 24.8±3.2 <0.001
Hemoglobin, g/dL 15.0±0.9 13.2±0.8 <0.001
Systolic blood pressure, mm Hg 121.9±16.5 119.4±18.1 <0.001
Diastolic blood pressure, mm Hg 77.8±10.0 71.9±10.1 <0.001
Total cholesterol, mg/dL 190.4±31.7 200.6±34.9 <0.001
Fasting glucose, mg/dL 99.4±21.7 95.1±18.4 <0.001
Blood urea nitrogen, mg/dL 16.3±4.3 15.2±4.3 <0.001
Serum creatinine, mg/dL 1.1±0.1 0.9±0.9 <0.001
Triglycerides, mg/dL 130 (94 to 193) 120 (86 to 168) <0.001
∗
Postmenopause N/A 2051 (75.8) N/A
Current alcohol drinking 1020 (62.6) 723 (26.7) <0.001
Current cigarette smoking 508 (31.2) 61 (2.3) <0.001
Regular physical activity 611 (37.5) 932 (34.4) 0.043
Diabetes 241 (14.8) 358 (13.2) 0.159
Hypercholesterolemia 484 (29.8) 819 (30.2) 0.756
Data expressed as mean± standard deviation, median (25%–75%), or number (%).
∗
Wilcoxon rank-sum test.
Kim et al. Medicine (2016) 95:41 www.md-journal.comand also higher frequencies of current alcohol drinking, diabetes,
and hypercholesterolemia, than those without hypertension
(Supplementary Table 1, http://links.lww.com/MD/B321). For
women, mean age, BMI, fasting glucose, BUN, creatinine, and
triglyceride levels were signiﬁcantly higher in the group with
hypertension. Postmenopause, diabetes, and hypercholesterol-
emia were more frequent in women with hypertension, whereas
current alcohol drinking was more common in those without
hypertension. Mean baseline hemoglobin concentrations were
signiﬁcantly higher in men and women with hypertension than in
those without hypertension (P=0.002 for men, P=0.006 for
women).Table 2
Cross-sectional association between hemoglobin concentrations an
Baseline hemoglobin, g/dL No. of people No. (%) of hypertension
Men
<14.3 361 111 (30.7)
14.3 to <15.0 440 142 (32.3)
15.0 to <15.6 394 141 (35.8)
≥15.6 434 174 (40.1)
Continuous (per 1 SD) 1629 568 (34.9)
Women
<12.6 682 224 (32.8)
12.6 to <13.1 581 176 (30.3)
13.1 to <13.7 712 227 (31.9)
≥13.7 733 293 (40.0)
Continuous (per 1 SD) 2708 920 (34.0)
Total
Q1 1043 335 (32.1)
Q2 1021 318 (31.1)
Q3 1106 368 (33.3)
Q4 1167 467 (40.0)
Continuous (per 1 SD) 4337 1488 (32.1)
Hemoglobin 1 SD: 1.2 g/dL.
∗
Model 1: unadjusted.
†Model 2: adjusted for age, body mass index, sex, and study year.
‡Model 3: adjusted for age, body mass index, sex, study year, menopausal status (only women), alcoho
diabetes, and hypercholesterolemia.
3Table 2 outlines the cross-sectional associations between
hemoglobin concentration and hypertension for men, women,
and all participants. In model 1, the fourth quartile group exhibited
signiﬁcantly higher odds for hypertension in men and women (OR
1.50, 95% conﬁdence interval [CI] 1.12–2.02 for men; OR 1.38,
95% CI 1.11–1.73 for women). After adjusting for age, BMI,
lifestyle factors, BUN, serum creatinine, and comorbidities, the
relationshippersisted,withstatisticallysigniﬁcantORsof1.47(95%
CI 1.06–2.05) for men and 1.39 (95% CI 1.09–1.77) for women.
Among all participants, the fourth quartile group showed a
signiﬁcantly higher OR of 1.42 (95% CI 1.19–1.73) than that of
the ﬁrst quartile. For model 2, and even model 3, which wasd hypertension at baseline.
Odds ratio (95% conﬁdence interval) for hypertension
Model 1
∗
Model 2† Model 3‡
1.00 1.00 1.00
1.07 (0.79–1.44) 1.12 (0.82–1.53) 1.08 (0.79–1.49)
1.25 (0.92–1.70) 1.29 (0.94–1.78) 1.24 (0.89–1.72)
1.50 (1.12–2.02) 1.62 (1.18–2.22) 1.47 (1.06–2.05)
1.24 (1.08–1.41) 1.27 (1.10–1.47) 1.20 (1.03–1.39)
1.00 1.00 1.00
0.90 (0.71–1.14) 0.98 (0.76–1.26) 0.97 (0.75–1.26)
0.96 (0.77–1.20) 1.04 (0.81–1.32) 1.03 (0.80–1.32)
1.38 (1.11–1.73) 1.43 (1.13–1.82) 1.39 (1.09–1.77)
1.19 (1.06–1.34) 1.20 (1.06–1.36) 1.17 (1.03–1.34)
1.00 1.00 1.00
0.96 (0.80–1.16) 1.04 (0.85–1.27) 1.03 (0.84–1.26)
1.06 (0.88–1.27) 1.14 (0.94–1.39) 1.13 (0.93–1.37)
1.42 (1.19–1.70) 1.53 (1.27–1.85) 1.44 (1.19–1.76)
1.11 (1.05–1.18) 1.25 (1.14–1.37) 1.20 (1.09–1.32)
l intake, smoking status (only men), regular physical activity, blood urea nitrogen, serum creatinine,
Figure 1. Cross-sectional association between hemoglobin and blood pressure in unadjusted model. Solid (dotted) lines present the odds ratio (95% conﬁdence
interval) for blood pressure in relation to hemoglobin, as a function of penalized regression splines.
Kim et al. Medicine (2016) 95:41 Medicineadditionally adjusted for age, BMI, lifestyle factors, BUN, serum
creatinine, and comorbidities, these associations persisted. We
also observed a signiﬁcant relationship of an increased prevalence
of hypertension per 1 standard deviation (SD) increase in
hemoglobin concentration in men, women, and all participants.
Hemoglobin concentration as a continuous value was also
associated with blood pressure with a linear shape (Fig. 1). Even
after excluding people with hypertension, hemoglobin showed
similar positive associations with SBP and DBP (Supplementary
Table 2, http://links.lww.com/MD/B321).
3.3. Longitudinal association between baseline
hemoglobin and incident hypertension
The RRs of incident hypertension at follow-up based on baseline
hemoglobin levels for men, women, and all participants areTable 3
Relative risk of incident hypertension at follow-up according to base
Baseline hemoglobin, g/dL No. of people No of hypertension (%)
Men
<14.3 159 19 (11.9)
14.3 to <15.0 172 25 (14.5)
15.0 to <15.6 159 24 (15.1)
≥15.6 164 16 (9.8)
Continuous (per 1 SD) 654 84 (12.8)
Women
<12.6 290 29 (10.0)
12.6 to <13.1 257 29 (11.3)
13.1 to <13.7 302 27 (8.9)
≥13.7 250 36 (14.4)
Continuous (per 1 SD) 1099 121 (11.0)
Total
Q1 449 48 (10.7)
Q2 429 54 (12.6)
Q3 461 51 (11.1)
Q4 414 52 (12.6)
Continuous (per 1 SD) 1753 205 (11.7)
Hemoglobin 1 SD: 1.2 g/dL.
∗
Model 1: unadjusted.
†Model 2: adjusted for age, body mass index, and sex.
‡Model 3: adjusted for age, body mass index, sex, menopausal status (only women), alcohol intake, smo
hypercholesterolemia, and baseline systolic blood pressure.
4shown in Table 3. Using model 1 for men, the RR of the fourth
quartile group was 0.82 (95% CI 0.44–1.53), lower than that for
the ﬁrst quartile group, although the association was not
signiﬁcant. Covariate adjustment did not signiﬁcantly change
the null association. For women, the fourth quartile group
exhibited a higher RR than the ﬁrst quartile group, although the
association was not signiﬁcant (RR 1.44, 95% CI 0.91–2.28).
After adjusting for age, BMI, lifestyle factors, BUN, serum
creatinine, baseline commodities, and baseline SBP, the nonsig-
niﬁcant relationship persisted.
Among all participants, similar results were found. Regardless
of adjustment, higher hemoglobin concentration was not
associated with hypertension incidence. When we assessed the
relationship between continuous hemoglobin and incident
hypertension, we failed to observe any signiﬁcant linear
relationships in men, women, and all participants (Fig. 2). Toline hemoglobin concentrations.
Relative risk (95% conﬁdence interval) for hypertension
Model 1
∗
Model 2† Model 3‡
Ref Ref Ref
1.22 (0.70–2.12) 1.27 (0.73–2.22) 1.00 (0.59–1.70)
1.26 (0.72–2.21) 1.28 (0.73–2.24) 1.01 (0.59–1.71)
0.82 (0.44–1.53) 0.85 (0.45–1.61) 0.59 (0.32–1.09)
0.94 (0.72–1.21) 0.95 (0.73–1.24) 0.79 (0.61–1.02)
Ref Ref Ref
1.13 (0.69–1.84) 1.19 (0.74–1.92) 1.10 (0.71–1.72)
0.89 (0.54–1.47) 0.91 (0.56–1.48) 0.90 (0.57–1.44)
1.44 (0.91–2.28) 1.39 (0.90–2.16) 1.04 (0.68–1.59)
1.21 (0.94–1.56) 1.18 (0.94–1.49) 1.01 (0.82–1.25)
Ref Ref Ref
1.18 (0.82 1.70) 1.20 (0.84–1.72) 1.02 (0.73–1.42)
1.04 (0.71–1.50) 1.02 (0.71–1.48) 0.94 (0.66–1.33)
1.18 (0.81–1.70) 1.13 (0.78–1.62) 0.85 (0.60–1.21)
1.09 (0.96–1.23) 1.05 (0.88–1.25) 0.91 (0.78–1.08)
king status (only men), regular physical activity, blood urea nitrogen, serum creatinine, diabetes, and
Figure 2. Longitudinal association between hemoglobin and incident
hypertension in unadjusted model. Solid (dotted) lines present the relative
risk (95% conﬁdence interval) for incident hypertension in relation to
hemoglobin, as a function of penalized regression splines.
Kim et al. Medicine (2016) 95:41 www.md-journal.comadjust for follow-up time, we also performed Cox proportional
hazards regression (Supplementary Table 3, http://links.lww.
com/MD/B321). However, the overall results of Cox propor-
tional-hazards regression were similar to those of the generalized
linear analysis, showing null association between hemoglobin
and hypertension incidence regardless of adjustment. To exclude
the effect of hypertensive drugs, we performed a further analysis
(Supplementary Table 4, http://links.lww.com/MD/B321). How-
ever, we could not ﬁnd an association between high hemoglobin
and high blood pressure at follow-up, regardless of sex.
4. Discussion
We observed a signiﬁcant positive association between hemoglo-
bin concentrations and the prevalence of hypertension in a rural
Korean population. Even after excluding participants with
hypertension at baseline, higher hemoglobin levels were
signiﬁcantly associated with higher SBP, DBP, and the presence
of hypertension. Nevertheless, we did not observe a signiﬁcant
association between baseline hemoglobin and incident hyperten-
sion in the longitudinal analysis. We also performed a stratiﬁed
analysis according tomenopausal status, which is another known
CVD risk factor[15,16]; however, the results did not change.
Previous studies have reported positive cross-sectional asso-
ciations between hemoglobin and blood pressure.[2–4,6,17] A
Dutch study reported that hemoglobin concentrations were
positively associated with SBP and DBP in men and women after
adjusting for age, BMI, and mean daily temperature.[2] A
Japanese study demonstrated that higher hemoglobin concen-
trations were associated with hypertension in nonobese men and
women.[3] In a Chinese study, higher hemoglobin concentrations,
even within the normal range, were associated with a higher
prevalence of hypertension and other cardiovascular risk
factors.[4] A Korean study reported that hemoglobin showed
signiﬁcant positive associations with hypertension, SBP, and DBP
in men and women after adjusting for age, BMI, total cholesterol,
alcohol intake, smoking status, mild renal dysfunction, and
diabetes mellitus.[6] Notwithstanding, a longitudinal relationship5between hemoglobin and incident hypertension has not been fully
evaluated.
Several mechanisms may explain the link between hemoglobin
and hypertension. One such potential mechanism is blood
viscosity, which may explain the positive cross-sectional
association between hemoglobin and blood pressure. Earlier
studies have reported that elevations of hematocrit and
hemoglobin increase blood viscosity, which may in turn elevate
blood pressure levels and worsen cardiovascular function.[17,18]
However, other studies reported that blood pressure was not
correlated with blood viscosity in healthy individuals,[10–12] due
to shear stress regulation in the normotensive population.[19,20]
However, this mechanism does not directly support the
hypothesis that increased hemoglobin concentration is a causal
factor of hypertension.
Other evidence suggests that a third factor may have an
inﬂuence on both hemoglobin concentration and hypertension.
First, the renin-angiotensin-aldosterone system may be related to
both hemoglobin concentration and blood pressure. Renin is
transformed to angiotensin-2, which causes vasoconstriction. In
this process, other tissues may produce angiotensin-2 and
stimulate erythropoietin production.[21,22] Second, endothelial
cell damage may inﬂuence on blood pressure, and also
hemoglobin concentration. An Italian study observed an inverse
relationship between hemoglobin and forearm endothelium-
dependent vasodilation in untreated hypertensive patients, but
not in normotensive people.[23] Endothelial cell damage is also
associated with the increased concentrations of growth factors[24]
to regenerate tissues.[25,26] Several studies have reported that the
concentration of serum hepatocyte growth factor concentration
is positively associated with hypertension,[27,28] and also an
increased hemoglobin concentration.[29] As growth factors
enhance hematopoiesis, which produces erythrocytes,[30] hemo-
globin levels may increase with increasing levels of growth
factors.[29]
The present study had several limitations. First, our study
population was limited to a single rural area and was not
randomly selected. Therefore, our ﬁndings may not be
generalizable to other populations. Second, although there was
a 4.4-year follow-up period, we could not observe the change in
hemoglobin concentration over this period. It is likely that the
hemoglobin varied widely in this period, particularly in cases of
women due to menstruation or delivery. Instead, we compared
mean hemoglobin for women at baseline and follow-up
according to status of menopause. However, we could not ﬁnd
a signiﬁcant difference in hemoglobin between premenopausal
and postmenopausal women (not shown). Third, our study
potentially introduced measurement errors. We measured
treatment history using a self-reported questionnaire; however,
misclassiﬁcation, if any, would likely be nondifferential misclas-
siﬁcation bias. Fourth, hemoglobin levels are mainly affected by
nutrition and iron metabolism; however, we did not control for
nutritional effects. Fifth, the cross-sectional results could have
shown a temporal association between hemoglobin and
hypertension. However, we used a longitudinal analysis to
counter this weak point of the study to explain the causality
between hemoglobin and the development of the hypertension.5. Conclusions
We reported a signiﬁcant positive association between hemoglo-
bin concentrations and the prevalence of hypertension in a rural
Korean population. Even after excluding participants with
[14] Hagstrom E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone
Kim et al. Medicine (2016) 95:41 Medicinehypertension at baseline, higher hemoglobin levels were
signiﬁcantly associated with higher SBP and DBP levels and
the presence of hypertension. We did not observe a longitudinal
association between higher hemoglobin and incident hyperten-
sion. Our ﬁndings suggest that higher hemoglobin per se may not
contribute to the development of hypertension, although high
hemoglobin levels are associated with high blood pressure in a
cross-sectional view.References
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